InvestorsHub Logo
Followers 11
Posts 190
Boards Moderated 0
Alias Born 06/28/2017

Re: None

Wednesday, 06/27/2018 12:31:50 PM

Wednesday, June 27, 2018 12:31:50 PM

Post# of 403025
IPIX is going to pop/skyrocket very soon $$$ I'm very confident and I'm in the industry... I've done my homework and there is a buyout imminent, BP knows B-OM and Brilacidin itself is a Franchise Blockbuster with all the unmet needs it can satisfy across numerous large market disease states.

Prurisol is another Billion dollar a year market, with advantages of being a Non Biologic, in a very large Psoriasis disease state based on the number of newly diagnosed patients every year and large numbers of second line patients that fail the others over time... e.g. (Ortezla). I expect the Prurisol data will be amazingly safe and highly efficacious based on preliminary public data already out there.

"In dermatology, the current focus is on managing Psoriasis with Prurisol. For cancer, the emphasis is on Ovarian Carcinomas, a gateway indication toward Kevetrin treating many other types of hematological malignancies and tumors. In the area of infectious disease, Acute Bacterial Skin and Skin Structure Infection (ABSSSI) is the target indication. As to gastrointestinal conditions, a study is underway evaluating Brilacidin's anti-microbial and anti-inflammatory properties in treating Inflammatory Bowel Disease. Brilacidin is also being tested in Oral Mucositis."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News